We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $191B
1-Year Est. Return 45.21%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
+9.31%
1 Year Est. Return
+45.21%
3 Year Est. Return
+136.44%
5 Year Est. Return
+183.49%
10 Year Est. Return
+678.03%
AUM
$162B
AUM Growth
+$12.2B
Cap. Flow
+$86.8M
Cap. Flow %
0.05%
Top 10 Hldgs %
24.82%
Holding
2,687
New
205
Increased
908
Reduced
1,482
Closed
45

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.07B
2
NEM icon
Newmont
NEM
+$149M
3
WM icon
Waste Management
WM
+$122M
4
MCD icon
McDonald's
MCD
+$113M
5
LLY icon
Eli Lilly
LLY
+$109M

Sector Composition

Rank Sector Weight
1 Technology 27.15%
2 Healthcare 14.17%
3 Consumer Discretionary 13.27%
4 Communication Services 11.59%
5 Industrials 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRAX icon
2526
Praxis Precision Medicines
PRAX
$10.3B
$877K ﹤0.01%
+3,200
New +$1.15M
MBIN icon
2527
Merchants Bancorp
MBIN
$2.5B
$871K ﹤0.01%
33,300
+3,750
+13% +$104K
VKTX icon
2528
Viking Therapeutics
VKTX
$3.94B
$870K ﹤0.01%
145,200
-4,800
-3% -$28.5K
CURI icon
2529
CuriosityStream
CURI
$166M
$869K ﹤0.01%
+63,700
New +$822K
EGIO
2530
DELISTED
Edgio, Inc. Common Stock
EGIO
$869K ﹤0.01%
6,900
UVE icon
2531
Universal Insurance Holdings
UVE
$1.19B
$859K ﹤0.01%
61,900
-6,500
-10% -$91.3K
FMTX
2532
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$859K ﹤0.01%
34,500
-700
-2% -$18.8K
BMRC icon
2533
Bank of Marin Bancorp
BMRC
$461M
$855K ﹤0.01%
26,800
-1,200
-4% -$42K
AKRO
2534
DELISTED
Akero Therapeutics
AKRO
$853K ﹤0.01%
34,400
-900
-3% -$25.3K
NGMS
2535
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$848K ﹤0.01%
+13,800
New +$720K
PMVP icon
2536
PMV Pharmaceuticals
PMVP
$69.3M
$844K ﹤0.01%
+24,700
New +$825K
WTTR icon
2537
Select Water Solutions
WTTR
$2.72B
$838K ﹤0.01%
138,800
LOTZ
2538
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$821K ﹤0.01%
+150,300
New +$948K
TG icon
2539
Tredegar Corp
TG
$275M
$814K ﹤0.01%
59,100
-1,800
-3% -$27.1K
SEER icon
2540
Seer Inc
SEER
$119M
$813K ﹤0.01%
+24,800
New +$978K
LOCO icon
2541
El Pollo Loco
LOCO
$452M
$808K ﹤0.01%
44,150
-1,700
-4% -$29.1K
BNFT
2542
DELISTED
Benefitfocus, Inc.
BNFT
$808K ﹤0.01%
57,300
-8,400
-13% -$118K
VAPO
2543
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$806K ﹤0.01%
4,263
+288
+7% +$49.1K
RLMD icon
2544
Relmada Therapeutics
RLMD
$477M
$803K ﹤0.01%
25,100
-4,600
-15% -$160K
POSH
2545
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$802K ﹤0.01%
+16,800
New +$720K
IMVT icon
2546
Immunovant
IMVT
$8.45B
$799K ﹤0.01%
75,600
-1,900
-2% -$26.5K
PLRX icon
2547
Pliant Therapeutics
PLRX
$63.8M
$798K ﹤0.01%
27,400
+3,400
+14% +$106K
TSHA icon
2548
Taysha Gene Therapies
TSHA
$2.14B
$795K ﹤0.01%
+37,500
New +$864K
CSTE icon
2549
Caesarstone
CSTE
$104M
$794K ﹤0.01%
53,800
DRRX
2550
DELISTED
DURECT Corp
DRRX
$794K ﹤0.01%
48,690
+2,270
+5% +$39.6K

Similar funds

Swiss National Bank's Q2 2021 Portfolio in Review

As of Q2 2021, Swiss National Bank held 2,687 positions worth $162B, up 8.1% from $150B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Swiss National Bank's Q2 2021 filing shows 205 new, 908 increased, 1,482 reduced and 45 closed positions. Its largest new stake was Lyft: 1,044,300 shares worth $63.2M. The largest sale was Alibaba, an estimated $1.07B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Swiss National Bank's largest Q2 2021 buy was Lyft: 1,044,300 shares worth $63.2M.
  • Swiss National Bank added most to Apple in Q2 2021, an estimated $370M increase.
  • Swiss National Bank's biggest Q2 2021 reduction was Newmont, cutting an estimated $149M.
  • Swiss National Bank fully exited Alibaba in Q2 2021, selling an estimated $1.07B.
  • Swiss National Bank's ten largest holdings make up 25% of its $162B portfolio in Q2 2021.
  • Swiss National Bank opened 205 new positions and closed 45 in Q2 2021.
  • Swiss National Bank's portfolio value rose 8.1% quarter-over-quarter to $162B.

Based on Swiss National Bank's 13F filing for Q2 2021, filed 6 Aug 2021.